Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ki-67 and p53 in T2 laryngeal cancer.

The Laryngoscope - 1 Oct 1998

Kropveld A, Slootweg P J, Blankenstein M A, Terhaard C H, Hordijk G J

Abstract excerpt

OBJECTIVE: To study the relationship between the proliferative capacity, represented by the immunohistochemical labeling index (LI) of proliferation marker Ki-67, and the p53 status, as in theory an intact p53 cell cycle checkpoint system should result in a lower proliferative capacity. STUDY DESIGN: From a group of 128 patients with a T2 laryngeal carcinoma, presented from 1989 to 1993 at the University Hospital...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Genes, p53

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9778299
DOI: 10.1097/00005537-199810000-00023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Ki-67 and p53 in T2 laryngeal cancer.PMID 9778299Read ↗

Human papillomavirus type, proliferative activity, and p53: potential markers of aggressive papillomatosis.Semantic proximity Read ↗

Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Influence of p53 and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients.Semantic proximity Read ↗

Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index.Semantic proximity Read ↗

Overexpression of Bcl‐2 in squamous cell carcinoma of the larynx: A marker of radioresistanceSemantic proximity Read ↗

p53 Expression and cell proliferation in squamous cell carcinomas of the head and neckSemantic proximity Read ↗

Retrospective analysis of Ki-67 antigen expression in paraffin tissue blocks of laryngeal squamous cell carcinoma.Semantic proximity Read ↗

Functional and phenotypic analysis of T-lymphocytes in laryngeal carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.